Company News

FDA Sends Warning Letter to Gilchrist & Soames

Inspection in Indiana turns up microbial contamination, insanitary practices.

Author Image

By: Christine Esposito

Editor-in-Chief

A warning letter has been sent to Gilchirst & Soames’ CEO Kathie De Voe following a U.S. Food and Drug Administration (FDA) inspection of the company’s cosmetic manufacturing facility in Plainfield, IN from Sept. 22 to Oct. 5, 2015.   The facility manufactures and distributes hotel amenity products, including shower gels, shampoos, lotions, and conditioners, to retail and charitable organizations.   In the letter, FDA says samples of “Gilchrist & Soames Spa Therapy Conditioni...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters